SELX NASDAQ Week ended 10 Jul 2026

Weekly Investor Report

Semilux International Ltd. Ordinary Shares · Technology · Electronic Components

Open interactive chart View report data
Latest close 0.34 USD
0.0% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -30.2% below the Trend Line and sits at 12.5% of its 52-week range. The latest completed week returned 0.0%, after a 0.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 49/100.

Setup score 20 out of 100
Latest Close 0.34 USD 10 Jul 2026
1W Return 0.0% latest completed week
4W Return 0.0% short-term follow-through
12W Return -23.4% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio - vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 40.25% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through 0.0% Latest completed week; four-week move 0.0%. Indicator stack 0/75 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.25% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 49/100 62 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -30.2% below the Trend Line and sits at 12.5% of its 52-week range. The latest completed week returned 0.0%, after a 0.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is - the 13-week average. Participation data is incomplete.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
16 Jan 23 Jan 30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.15

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.0% over four weeks, -23.4% over 12 weeks, and -70.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.0%
4W0.0%
12W-23.4%
26W-59.7%
52W-70.9%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.46Latest activity-pressure read.
Pressure change213.9%Four-week change in activity pressure.
Leadership-57.47Latest relative-leadership reading.
RS change7.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Sep 2025 Field coverage 82% Model confidence 55%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength38/100Blend of value, momentum, and quality. Underlying universe rank 63; rank 1 is best.
Value44/100Relative valuation strength. Underlying universe rank 57; rank 1 is best.
Quality43/100Profitability and accounting quality. Underlying universe rank 58; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth45/100Revenue and earnings growth. Underlying universe rank 56; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
205.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-23.7%
Gross profit retained from each unit of revenue.
Operating margin
-124.3%
Operating profit retained from revenue.
Free-cash-flow margin
19.4%
Free cash flow generated from revenue.
Return on invested capital
-45.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
0.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 62 relevant articles.

2 positive · 58 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-74.2%Distance below the 52-week high.
13-week volatility15.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2613 weeks finished lower.
Best week+52.3%Week of 3 Apr.
Worst week-39.2%Week of 8 May.
Latest week+0.0%Week of 10 Jul.

Shape of recent returns

Strong gains6
Modest gains2
Flat weeks5
Modest losses2
Sharp losses11
Recent vol15.4%13-week weekly-return volatility.
Base vol18.7%52-week weekly-return volatility.
Up/down split19/27Count of positive and negative weeks in the 52-week window.
Average skew15.3% / -12.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape20/100

Trend, activity pressure, participation, and risk combine to a 20/100 tape read.

 Indicator analysis16/100

Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.

Activity pressure 0.14; No reversal markers Next-Week ExpectancyNegative 40.25%

Next-week expectancy is negative with a 40.25% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors41/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 52 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment49/100

Weighted news tone is neutral across 62 relevant articles.

Semilux International Ltd. Revenue Breakdown – OTC:SELXF Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
10 Jul 20260.34 USD0.0%0.49 USD1.17 USD0.46-57.470Off
3 Jul 20260.34 USD0.0%0.50 USD1.18 USD0.44-57.910Off
26 Jun 20260.34 USD0.0%0.51 USD1.19 USD0.37-58.760Off
19 Jun 20260.34 USD0.0%0.51 USD1.19 USD-0.03-61.750Off
12 Jun 20260.34 USD0.0%0.52 USD1.20 USD-0.41-61.900Off
5 Jun 20260.34 USD30.3%0.54 USD1.21 USD-0.71-62.24193.8MOff
29 May 20260.26 USD-10.0%0.55 USD1.22 USD-1.07-73.12970.3KOff
22 May 20260.29 USD20.2%0.57 USD1.22 USD-1.03-70.34437.0KOff
15 May 20260.24 USD0.5%0.58 USD1.23 USD-0.99-75.96863.5KOff
8 May 20260.24 USD-39.2%0.61 USD1.24 USD-0.93-77.031.1MOff
1 May 20260.40 USD-6.3%0.63 USD1.25 USD-0.79-61.59151.1KOff
24 Apr 20260.42 USD-5.0%0.65 USD1.26 USD-0.55-59.70411.6KOff
17 Apr 20260.44 USD6.6%0.67 USD1.26 USD-0.57-58.013.2MOff
10 Apr 20260.42 USD-21.2%0.69 USD1.27 USD-0.56-59.419.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.